Study of Ixazomib and Erlotinib in Solid Tumors
Clinical trial NCT02942095 · COMPLETED
Trial details
- NCT number
- NCT02942095
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2022-12-07
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.